Literature DB >> 2178657

Short term haemodynamic effects of converting enzyme inhibition before and after eating in patients with moderate heart failure caused by dilated cardiomyopathy: a double blind study.

B Herrlin1, C Sylvén, O Nyquist, O Edhag.   

Abstract

The haemodynamic changes that follow a meal can mimic the response to a vasodilator drug. To avoid overestimating the beneficial effects of treatment in uncontrolled studies, measurements of haemodynamic function are usually performed with patients in the fasting postabsorptive state. But such recordings are not representative of the resting patient during daily life. In this double blind placebo controlled study the short term haemodynamic effects of enalapril were assessed during 12 hours in 19 patients with moderate heart failure caused by dilated cardiomyopathy. The patients ate lunch and dinner and were studied in the absorptive and postabsorptive phases. In the placebo group systemic vascular resistance, mean arterial pressure, and the rate-pressure product fell significantly (5-16%) after lunch. Four hours after lunch the haemodynamic function had returned to baseline--that is the postabsorptive state. Enalapril, accentuated the haemodynamic effects during the absorptive state producing a larger post-prandial fall in mean arterial blood pressure and rate-pressure product and changes in the absorptive phase were maintained into the post-absorptive phase. Pulmonary wedge pressure fell significantly after treatment with enalapril. These overall changes during the study period indicated that enalapril reduced the preload and afterload on the heart--over and above the reduction produced by eating. These findings suggest that the effects of enalapril given at rest to patients with moderate heart failure unload the heart and enhance the reduction of afterload induced by meals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178657      PMCID: PMC1024310          DOI: 10.1136/hrt.63.1.26

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  26 in total

1.  Superior mesenteric blood flow during digestion in man.

Authors:  C Norryd; H Denker; A Lunderquist; T Olin; U Tylén
Journal:  Acta Chir Scand       Date:  1975

2.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.

Authors:  J A Patterson; J Naughton; R J Pietras; R M Gunnar
Journal:  Am J Cardiol       Date:  1972-11       Impact factor: 2.778

3.  Effect of digestion and exercise on intestinal blood flow and cardiac output. An experimental study in the conscious dog.

Authors:  G P Burns; W G Schenk
Journal:  Arch Surg       Date:  1969-06

4.  The spontaneous occurrence of paroxysmal supraventricular tachycardia.

Authors:  E L Pritchett; M S Smith; E A McCarthy; K L Lee
Journal:  Circulation       Date:  1984-07       Impact factor: 29.690

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  Regional blood flow during digestion in the conscious dog.

Authors:  R H Gallavan; C C Chou; P R Kvietys; S P Sit
Journal:  Am J Physiol       Date:  1980-02

7.  Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

Authors:  J Biollaz; J L Schelling; B Jacot Des Combes; D B Brunner; G Desponds; H R Brunner; E H Ulm; M Hichens; H J Gomez
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

8.  Splanchnic and overall cardiovascular hemodynamics during eating and digestion.

Authors:  C C Chou
Journal:  Fed Proc       Date:  1983-04

9.  Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

Authors:  T B Levine; M T Olivari; V Garberg; S W Sharkey; J N Cohn
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

Review 10.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

View more
  3 in total

Review 1.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Haemodynamic effects of eating.

Authors:  G D Oakley
Journal:  Br Heart J       Date:  1990-01

3.  Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.

Authors:  B Beermann; O Nyquist; C Höglund; K A Jacobsson; U Näslund; M Jensen-Urstad
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.